Lidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), package...

FDA Recall #D-0229-2026 — Class II — October 31, 2025

Recall #D-0229-2026 Date: October 31, 2025 Classification: Class II Status: Ongoing

Product Description

Lidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Patterson Dental Supply, Inc., 1031 Mendota Heights Road, Saint Paul, MN55120, Manufactured by: Novocol Pharmaceutical of Canada, Inc., NDC 50227-1030-5.

Reason for Recall

Defective container: cracked/broken cartridges

Recalling Firm

Novocol Pharmaceutical of Canada, Inc. — Cambridge

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

12,033 cartons

Distribution

U.S.A. Nationwide

Code Information

Lot: D05362A, expires: 07-31-2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated